Caption Health, a leading medical artificial intelligence (AI) company, concluded its Series B funding round with $53 million to expand and commercialize its FDA-cleared, AI-guided ultrasound technology that improves patient access to high-quality and essential care. The strategy is to use this investment to scale commercial operations, continue to develop its AI technology platform, and form new partnerships. New clinical capabilities are planned with increased clinical adoption of the Caption AI platform.
MedRhythms Inc., a digital therapeutics startup based in Portland, Maine, has received FDA breakthrough device designation for its Rhythmic Auditory Stimulation (RAS) treatment platform for people with chronic walking impairments due to stroke. This product is the first in the Company's pipeline of digital therapeutics for neurologic disease and injury.
In the U.S. healthcare ecosystem, digital solutions pose unique challenges to the implementation of major change efforts. However, a new McKinsey Global Survey suggests the capabilities that support better outcomes remain as critical as ever, a new survey shows. Across all types of transformations successful implementations remain unspecific, with few survey respondents responding that their organizations’ change efforts have both improved performance and sustained those improvements.